ライフサイエンスコーパス: healthcare research

1 l challenges of using Twitter in nursing and healthcare research.

2 ng patient reported outcomes instruments for healthcare research.

3 the equivalent parallels and track record in healthcare research.

4 recent clinical trials, patient outcomes and healthcare research.

5 ypes of prespecified locations to facilitate healthcare research and patient care.

6 st and Utilization Project of the Agency for Healthcare Research and Quality (2006-2011).

7 el Survey (MEPS), provided by the Agency for Healthcare Research and Quality (AHRQ) for 2010 to calcu

8 The Agency for Healthcare Research and Quality (AHRQ) pediatric quality

9 e Center (EPC) program within the Agency for Healthcare Research and Quality (AHRQ) provides detailed

10 inghouse and in print through the Agency for Healthcare Research and Quality (AHRQ) Publications Clea

11 ionwide Inpatient Sample from the Agency for Healthcare Research and Quality (AHRQ), we evaluated the

12 he NYC mean with inclusion of the Agency for Healthcare Research and Quality (AHRQ)-validated SES ind

13 s through a project funded by the Agency for Healthcare Research and Quality (AHRQ).

14 nal Inpatient Sample (NIS) of the Agency for Healthcare Research and Quality (AHRQ).

15 and Utilization Project from the Agency for Healthcare Research and Quality (AHRQ).

16 prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations

17 standardized forms, staff of the Agency for Healthcare Research and Quality abstracted data on study

18 ture on the topic provided by the Agency for Healthcare Research and Quality and an extensive bibliog

19 Agency for Healthcare Research and Quality and National Cancer Inst

20 Agency for Healthcare Research and Quality and National Heart, Lung

21 Agency for Healthcare Research and Quality and National Institute o

22 Agency for Healthcare Research and Quality and National Institute o

23 Primary Funding Source: Agency for Healthcare Research and Quality and National Science Fou

24 Agency for Healthcare Research and Quality and National Science Fou

25 , and additional funding from the Agency for Healthcare Research and Quality and private philanthropy

26 Agency for Healthcare Research and Quality and RAND Corporation.

27 y indicators (PSI) defined by the Agency for Healthcare Research and Quality and six experimental PSI

28 Agency for Healthcare Research and Quality and the Harvard Program

29 INTRODUCTION: The Agency for Healthcare Research and Quality and the Leapfrog Group u

30 Agency for Healthcare Research and Quality and the National Institu

31 Agency for Healthcare Research and Quality and the U.S. Department

32 recent landmark reports from the Agency for Healthcare Research and Quality are presented.

33 Safety Indicators (PSIs) from the Agency for Healthcare Research and Quality are validated measures o

34 nsive care units in Michigan, the Agency for Healthcare Research and Quality awarded a grant to sprea

35 Agency for Healthcare Research and Quality class A controlled trial

36 The Agency for Healthcare Research and Quality commissioned 2 systemati

37 In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although

38 f Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop invo

39 icare reimbursement rates and the Agency for Healthcare Research and Quality Database were used to es

40 ngs of a technical report for the Agency for Healthcare Research and Quality describing MAT models of

41 Although Agency for Healthcare Research and Quality disease severity and mor

42 ioned as a technical brief by the Agency for Healthcare Research and Quality Effective Health Care Pr

43 the best available evidence, the Agency for Healthcare Research and Quality established a network of

44 In 2003, the Agency for Healthcare Research and Quality established Patient Safe

45 The 2001 Agency for Healthcare Research and Quality Evidence Report dismissi

46 An Agency for Healthcare Research and Quality evidence report of studi

47 A 2001 Agency for Healthcare Research and Quality Evidence Report on patie

48 cians nominated this topic to the Agency for Healthcare Research and Quality Evidence-Based Practice

49 National Institute of Health and Agency for Healthcare Research and Quality funded a two-state colla

50 The Agency for Healthcare Research and Quality has devoted a substantia

51 ective Health Care Program of the Agency for Healthcare Research and Quality involved stakeholders in

52 rom the nationally representative Agency for Healthcare Research and Quality Kids' Inpatient Database

53 We used Agency for Healthcare Research and Quality Patient Safety Indicator

54 nce-based Practice Centers in the Agency for Healthcare Research and Quality program produced 11 repo

55 Web site and in print through the Agency for Healthcare Research and Quality Publications Clearinghou

56 SES was measured using the Agency for Healthcare Research and Quality SES index using data fro

57 Indicators were calculated using Agency for Healthcare Research and Quality software (Win QI, versio

58 The Agency for Healthcare Research and Quality sponsored an internation

59 Modification billing data from 3 Agency for Healthcare Research and Quality State Inpatient Database

60 We used the Agency for Healthcare Research and Quality State Inpatient Database

61 ase of Systematic Reviews and the Agency for Healthcare Research and Quality Systematic Review Data R

62 RECENT DATA: Evidence from a 2011 Agency for Healthcare Research and Quality systematic review primar

63 The Agency for Healthcare Research and Quality Technology Assessment Pr

64 ategories using software from the Agency for Healthcare Research and Quality to describe clinically r

65 eport through a contract with the Agency for Healthcare Research and Quality to facilitate the discus

66 eport through a contract with the Agency for Healthcare Research and Quality to facilitate the worksh

67 and Utilization Project from the Agency for Healthcare Research and Quality was analyzed.

68 then screened for iAEs using the Agency for Healthcare Research and Quality's 15 Patient Safety Indi

69 The Agency for Healthcare Research and Quality's Evidence-based Practic

70 mote performance improvement, the Agency for Healthcare Research and Quality's National Quality Measu

71 d a retrospective analysis of the Agency for Healthcare Research and Quality's Nationwide In-patient

72 y surgical complication (from the Agency for Healthcare Research and Quality's patient safety indicat

73 primary outcomes, we applied the Agency for Healthcare Research and Quality's Patient Safety Indicat

74 DLINE (1966 to October 2012), the Agency for Healthcare Research and Quality's Patient Safety Network

75 stroke using definitions from the Agency for Healthcare Research and Quality's stroke mortality Inpat

76 om the State Inpatient Databases (Agency for Healthcare Research and Quality), including >700,000 RSV

77 om the State Inpatient Databases (Agency for Healthcare Research and Quality).

78 sed Safety Program, funded by the Agency for Healthcare Research and Quality, aimed to reduce cathete

79 National Science Foundation, Agency for Healthcare Research and Quality, and National Institutes

80 he National Institutes of Health, Agency for Healthcare Research and Quality, and Office of the Secre

81 .S. Food and Drug Administration, Agency for Healthcare Research and Quality, and Public Health Agenc

82 sease Control and Prevention, the Agency for Healthcare Research and Quality, and the National Cancer

83 MEDLINE, EMBASE, Biosis, the Agency for Healthcare Research and Quality, National Guideline Clea

84 Agency for Healthcare Research and Quality, National Institutes of

85 PRIMARY FUNDING SOURCE: The Agency for Healthcare Research and Quality, the United Health Found

86 Under the auspices of the Agency for Healthcare Research and Quality, the United States Preve

87 Agency for Healthcare Research and Quality, United Health Foundatio

88 re and Medicaid Services, and the Agency for Healthcare Research and Quality-have heightened nationwi

89 on the procedure outlined by the Agency for Healthcare Research and Quality.

90 Agency for Healthcare Research and Quality.

91 eport through a contract with the Agency for Healthcare Research and Quality.

92 Primary Funding Source: Agency for Healthcare Research and Quality.

93 st and Utilization Project of the Agency for Healthcare Research and Quality.

94 National Institutes of Health and Agency for Healthcare Research and Quality.

95 l specifications published by the Agency for Healthcare Research and Quality.

96 grading scheme recommended by the Agency for Healthcare Research and Quality.

97 Agency for Healthcare Research and Quality.

98 National Institutes of Health and Agency for Healthcare Research and Quality.

99 Agency for Healthcare Research and Quality.

100 ational Institutes of Health, and Agency for Healthcare Research and Quality.

101 PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

102 Primary Funding Source: Agency for Healthcare Research and Quality.

103 Agency for Healthcare Research and Quality.

104 ational Institutes of Health, and Agency for Healthcare Research and Quality.

105 Agency for Healthcare Research and Quality.

106 National Institutes of Health and Agency for Healthcare Research and Quality.

107 Agency for Healthcare Research and Quality.

108 sease Control and Prevention, and Agency for Healthcare Research and Quality.

109 forts through a contract with the Agency for Healthcare Research and Quality.

110 on criteria and risk model of the Agency for Healthcare Research and Quality.

111 r Medicare and Medicaid Services; Agency for Healthcare Research and Quality; and US Department of Ve

112 Agency for Healthcare Research and Quality; Canadian Institutes of

113 Agency for Healthcare Research and Quality; National Heart, Lung, a

114 Ethical considerations in healthcare research are paramount, but current HIPAA imp

115 ng methodological frameworks used to measure healthcare research impact and to summarise the common t

116 Rosenkranz Prize for Healthcare Research in Developing Countries and US Natio

117 overall score on the Art of Medicine survey (HealthCare Research, Inc., Denver, Colorado), which meas

118 t appropriate way of measuring the impact of healthcare research is subject to debate.